TRUE Private Wealth Advisors Grows Holdings in The Clorox Company (NYSE:CLX)

TRUE Private Wealth Advisors raised its position in The Clorox Company (NYSE:CLXFree Report) by 12.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,121 shares of the company’s stock after purchasing an additional 458 shares during the period. TRUE Private Wealth Advisors’ holdings in Clorox were worth $588,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Tyler Stone Wealth Management purchased a new position in Clorox during the second quarter worth approximately $25,000. Fortitude Family Office LLC purchased a new position in shares of Clorox in the 4th quarter worth $29,000. Strategic Investment Solutions Inc. IL acquired a new position in Clorox in the first quarter valued at $31,000. First Capital Advisors Group LLC. acquired a new stake in Clorox during the second quarter worth about $35,000. Finally, Hartford Financial Management Inc. raised its holdings in shares of Clorox by 57.1% in the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after purchasing an additional 93 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.1 %

NYSE:CLX opened at $142.29 on Thursday. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21. The firm has a market capitalization of $17.66 billion, a P/E ratio of 225.86, a P/E/G ratio of 2.22 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The business has a 50 day simple moving average of $150.40 and a 200 day simple moving average of $141.69.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the previous year, the firm posted $0.98 EPS. The firm’s quarterly revenue was up 16.0% on a year-over-year basis. Equities research analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.37%. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Analyst Ratings Changes

A number of equities analysts have recently commented on CLX shares. Deutsche Bank Aktiengesellschaft cut their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday. Barclays dropped their target price on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. JPMorgan Chase & Co. raised their target price on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a report on Thursday, January 18th. The Goldman Sachs Group began coverage on Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price objective on the stock. Finally, DA Davidson restated a “neutral” rating and set a $162.00 price objective on shares of Clorox in a report on Wednesday. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $148.63.

Get Our Latest Research Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.